Oct 8, 2015 by Brian FeroldiCardiovascular Systems Inc is Crashing Today: Here's WhyCardiovascular Systems falls hard after reporting preliminary quarterly results. Here's what investors need to know.
Oct 6, 2015 by Brian FeroldiWhy Biotech Stocks Were Crushed, AgainShares of biotech stocks get hit hard once again. Did anything happen today to justify the move?
Oct 6, 2015 by Brian FeroldiWould an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?
Oct 6, 2015 by Brian FeroldiWhy Shares of Sarepta Therapeutics Inc Are Falling TodayA capital raise disappoints investors, sending shares lower.
Oct 6, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDSarepta Therapeutics vs. BioMarin Pharmaceutical: Which Company Will Win the DMD Race?Which of these two companies will win the race to successfully develop the first Duchenne muscular dystrophy treatment? Our team of contributors weigh in.
Oct 6, 2015 by Brian Feroldi, Sean Williams, and Cheryl Swanson3 Biotech Stocks That Have Been Unfairly Beaten DownBiotech stocks have been under attack recently, but which names have fallen the hardest for reasons that have nothing to do with the companies' performance?
Oct 5, 2015 by Brian Feroldi, George Budwell, PhD, and Cheryl Swanson3 Stocks with Strong Competitive PositionsLooking for a healthcare stock with a strong competitive position? Our Motley Fool contributors think you should give these 3 names a look.
Oct 5, 2015 by Brian Feroldi3 Reasons ISIS Pharmaceuticals Is a BuyAn enviable pipeline and a lower valuation make may now a good time to pick up shares in this RNA leader.
Oct 5, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Eric Volkman, and Jason Hall5 High-Yielding Dividend Stocks to Buy in OctoberInterested in investing in high-yield dividend stocks? Our contributors think these five names deserve spots on your watch list.
Oct 4, 2015 by Brian Feroldi, Selena Maranjian, and Cheryl Swanson3 Rock-Solid Dividend Stocks You Can Buy Right NowLooking for dependable income? Here are 3 healthcare stocks that we think you can count on to be reliable dividend payers for years to come.
Oct 3, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDForget Big Pharma: These Little Stocks Offer Far Richer Investing OpportunitiesAre you interested in investing in pharma stocks but don't want to put money to work in the big boys? These stocks should be on your radar.
Oct 2, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Speculative Growth Stocks That Might Be Worth the RiskLooking for a few growth stocks that could power your portfolio higher? Our contributors think these 3 names deserve a look.
Oct 2, 2015 by Brian FeroldiAre Medtronic's Competitors Finally Catching Up?Small- and mid-cap companies that compete with Medtronic's diabetes division are releasing new products, which may spell trouble for the company in the long term.
Oct 1, 2015 by Brian FeroldiWhy This Small-Cap Healthcare Stock Can Continue to WinThis small-cap specialty generic pharmaceutical manufacturer's stock has been a rocket ship in recent years, and the trend has a chance of continuing.
Sep 30, 2015 by Brian FeroldiWhy Shares of Novavax Inc Are Surging Higher TodayPositive phase 2 data and an $89 million grant sent the vaccine maker's stock higher.
Sep 29, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDWhich Big Pharma Will Grab the Lion’s Share of the Cancer Immunotherapy Market?Cancer immunotherapy is one of the hottest areas of cancer research these days, and the market looks to be worth billions. Which big pharma do we think will be the biggest winner in the space?
Sep 29, 2015 by Brian FeroldiRegeneron Pharmaceuticals and Sanofi Grab Another Important WinPraulent, the companies' new cholesterol-lowering medication, gets the regulatory green light in Europe.
Sep 29, 2015 by Brian Feroldi, Selena Maranjian, Sean Williams, Dan Caplinger, and Jordan Wathen5 High-Dividend Stocks to Avoid This FallAre these high yielding dividend stocks on your radar? If so, our contributors explain why you may want to rethink making an investment in them.
Sep 28, 2015 by Brian FeroldiWhy Biotech Got Crushed Last WeekThis is what happens when politics and the stock market collide.
Sep 28, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhDWhich Emerging Pharma Market Offers the Best Opportunity for Investors?Emerging markets around the world are becoming richer, and their spending on healthcare is bound to grow. Which markets should investors be paying the most attention to?
